Tourniquet and Quadricepsforce

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

July 31, 2014

Conditions
OsteoarthritisTotal Knee Arthroplasty
Interventions
DEVICE

Tourniquet

hyperbaric bupivacaine 12.5-15 mg Celecoxib 400 mg and paracetamol 1 g will be given preoperatively. Postoperatively celecoxib 200 mg x 2 and paracetamol 1 g/6 h is given is given for 2 weeks.

Trial Locations (1)

281 25

Dept Orthopedic surgery, Hässleholm Hospital, Hässleholm

All Listed Sponsors
lead

Region Skane

OTHER

NCT01808859 - Tourniquet and Quadricepsforce | Biotech Hunter | Biotech Hunter